Literature DB >> 24341478

A Scandinavian case of skin fragility, alopecia and cardiomyopathy caused by DSP mutations.

A Vahlquist1, M Virtanen, M Hellström-Pigg, A Dragomir, K Ryberg, N J Wilson, I Östman--Smith, L Lu, J A McGrath, F J D Smith.   

Abstract

Congenital skin fragility is a heterogeneous disorder with epidermolysis bullosa and various skin infections as the leading causes. However, even rare diseases must be considered in the differential diagnosis of neonatal skin blistering, including some genetic syndromes with extracutaneous involvement. One such syndrome is ectodermal dysplasia due to deficiency of desmoplakin, a desmosomal protein essential for cellular cohesion in both epithelia and cardiac tissues. Desmoplakin is encoded by the DSP gene, which is localized on chromosome 6p24. Both dominant and recessive mutations in this gene have been reported to cause skin fragility and keratinization defects. We report a child born with a fragile epidermis, alopecia, thick nails, and focal hyperkeratoses on the digits and knees. She was found to have a deficiency of desmoplakin caused by compound heterozygous DSP mutations. She has gradually developed signs of a left ventricular cardiomyopathy.
© 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24341478     DOI: 10.1111/ced.12226

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.

Authors:  Oyediran Akinrinade; Laura Ollila; Sanna Vattulainen; Jonna Tallila; Massimiliano Gentile; Pertteli Salmenperä; Hannele Koillinen; Maija Kaartinen; Markku S Nieminen; Samuel Myllykangas; Tero-Pekka Alastalo; Juha W Koskenvuo; Tiina Heliö
Journal:  Eur Heart J       Date:  2015-06-17       Impact factor: 29.983

2.  DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy.

Authors:  Krista Heliö; Tiia Kangas-Kontio; Sini Weckström; Sari U M Vanninen; Katriina Aalto-Setälä; Tero-Pekka Alastalo; Samuel Myllykangas; Tiina M Heliö; Juha W Koskenvuo
Journal:  BMC Med Genet       Date:  2020-01-31       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.